. (“Allied”) (
OTCQB: ALID) – an international medical company focused on creating and providing health solutions to address today’s medical mental health issues is pleased to announce that it has signed a letter of intent (LOI) with Fiore Cannabis Ltd. (CSE: FIORE) (“Fiore”) to acquire a US registered cultivation license located within in the State of Nevada, USA. In addition to this, the LOI contemplates a land lease agreement for the land foot print upon which the ready built Allied 9000 square foot building will be installed.
Allied has completed the construction of a $3.5 million, 9000 square foot, GMP-complaint facility that is ready to be deployed from the Las Vegas construction factory. The building has ample space for cannabis cultivation and research, as well as, large scale product packaging and fulfillment. In addition to this, Allied has reserved a space within this building to conduct Psilocybin research and production as the legislation allows. This build
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Allied Moves to Become Leader in Psilocybin Space with Intent to Acquire of Pacific Sun Fungi
Allied Corp.December 24, 2020 GMT
KELOWNA, British Columbia, Dec. 24, 2020 (GLOBE NEWSWIRE) Allied Corp. (“Allied”) (OTCQB: ALID) – an international medical cannabis company focused on creating and providing health solutions to address today’s medical mental health issues is pleased to announce the signing of a letter of intent to acquire the psilocybin company Pacific Sun Fungi (“Pacific Sun”). This further expands upon Allied’s press release of October 20, 2020 communicating the submission of the provisional patent for Allied’s functional mushroom formulation targeting major depression and anxiety.
Share:
KELOWNA, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE) Allied Corp
. ( Allied ) (OTCQB:ALID) – an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today s medical issues is pleased to announce the approval of its wholly owned subsidiary SECFAC Exchange Corporation (dba Allied Corp Pharmaceuticals ( Allied Pharma )) as an Eligible Business Corporation (EBC) in British Columbia (BC), Canada. This program allows BC investors who purchase shares in Allied Pharma to obtain an immediate 30% tax credit on their investment if they invest through a registered EBC. As an example, an investor making a $100,000 investment in Allied would receive a $30,000 tax credit, thereby providing an immediate return on their original investment. A BC accredited individual investor may invest an annual maximum of $400,000. The investment is RRSP and TFSA eligible. There is no investment limit to BC corporate investors
About Allied Corp.
Allied Corp. is an international medical cannabis production company with a mission to address today’s medical issues by researching, creating and producing targeted cannabinoid health solutions. Allied Corp. uses an evidence-informed scientific approach to make this mission possible, through cutting-edge pharmaceutical research and development, innovative plant-based production and unique development of therapeutic products.
About Tactical Relief: https://tacticalrelief.com/cbdproducts/
Tactical Relief™ is a lifestyle brand that focuses on the licensing, development, and marketing of products around its life-style message for those suffering from symptoms of post-traumatic stress and traumatic brain injury. Specifically, Tactical Relief™ provides products and resources to veterans and first responders.